Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2017

Feb 3, 2017

29745_dirs_2017-02-03_ddc725b5-1870-4367-bdc0-859c2938a5ef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-02-01

Reporting Person: Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-01 Common Stock M 3073 Acquired 17361 Direct
2017-02-01 Common Stock F 1420 $77.03 Disposed 15941 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-01 Restricted Stock Unit $ M 3073 Disposed 2017-02-01 Common Stock (3073.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 853 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.